Author
Pfizer (United States)ORCID 0000-0002-8442-637XUnclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Wei J. Chen, Kristin R. Tompkins, Ian W. Windsor…·Kayvon Modjarrad
Omicron JN.1- and KP.2-adapted BNT162b2 mRNA vaccines elicit stronger neutralizing antibody responses against circulating sublineages than previous vaccines, supporting annual strain updates.
Brooke A. Conti, Leo Novikov, Deyan Tong…·Mariano Oppikofer
The paper identifies METTL3 and N6-methyladenosine (6mA) as factors promoting genome stability by repairing DNA base lesions.
Kayvon Modjarrad, Ye Che, Wei Chen…·Kena A. Swanson
The monovalent Omicron XBB.1.5-adapted BNT162b2 mRNA vaccine elicits stronger neutralizing antibody responses against XBB.1.5 and related sublineages than the bivalent Wild Type + Omicron BA.4/5 vaccine.
David Jon Wasilko, Brian S. Gerstenberger, Kathleen A. Farley…·Huixian Wu
This paper presents two inactive CCR6 structures bound to allosteric antagonists, revealing structural insights into CCR6 inhibition and its implications for drug discovery.